We next applied the quantitative insulin and C-peptide method to plasma samples from a previous study of healthy control subjects and people with T2DM, taken following a 75 g oral glucose tolerance test, for which immunoassay-based insulin measurements were already published [33]. This evidence concerns the gene INS and type 2 diabetes mellitus.